A very low viral load (20-49 copies/ml) during HIV therapy does not increase the risk of the subsequent virological failure of treatment (viral load above 200 copies/ml), according to Spanish research published in HIV Medicine. The findings of the study will provide reassurance that patients with ...

Estimates of net prices and usage in the U.S. and other major markets The report examines the actual cost of hepatitis C treatments across multiple countries, focusing on media reporting of net prices negotiated between manufacturers and intermediaries. It seeks to go beyond the typical examination ...

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 296 of the “Global Fund Observer.” The newsletter features articles on various topics, including the outcomes of the Global Fund’s fifth replenishment conference and whether ending ...

The last line of defense against the STI is weakening; however, an experimental treatment showed promise in a recent Phase II trial. If current trends continue, strains of gonorrhea could become resistant to all available antibiotics, putting the 800,000 Americans who contract the sexually transmitted infection ...

University of Hawaiʻi researchers have identified a unique epigenetic footprint in specific types of immune cells from blood that can identify individuals with HIV that have a range of impairments in cognitive function. Reliable biomarkers such as that identified by the researchers offer insight into how ...

GENEVA, 20 September 2016—UNAIDS applauds all donors and partners for their demonstration of a strong commitment to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). At its Fifth Replenishment Conference in Montreal, Canada, donors pledged US$ 12.9 billion of the US$ 13 ...

MONTREAL, 17 September 2016 – At the launch of the Global Fund’s Fifth Replenishment, donors pledged over US$12.9 billion for the next three years, demonstrating extraordinary global commitment toward ending the epidemics of AIDS, tuberculosis and malaria for good. Hosted by Prime Minister Justin Trudeau, who ...

The 66th session of the WHO Regional Committee for Europe was held in Copenhagen, Denmark on 12-15 September. Representatives from the 53 countries in the WHO European Region debated a set of action plans that affect public health. On September 14 Member States adopted Action ...

The 18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV was held from 12-13 September 2016 in New York. This long-running workshop, initially set up to look at lipodystrophy, continues to be an important focus for research into side effects of ART and other ...

September 16, 2016: All patients beginning hepatitis C (HCV) treatment using direct acting antiviral (DAA) therapies should be assessed for hepatitis B (HBV), according the American Association for the Study of Liver Diseases/Infectious Diseases Society of America Guidance Panel, which provides up-to-date guidance on the ...

EPALINGES, Switzerland, Sept. 19, 2016 — Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious agents across mucosal membranes, announced today the continuation of the collaboration with the Texas Biomedical Research Institute related to ...

The Food and Drug Administration is announcing that the following HIV drug labels have been updated to include Latuda (lurasidone), an antipsychotic used to treat adult patients with depressive episodes in bipolar I disorder (bipolar depression), and schizophrenia, in adults. Lurasidone was added to Section ...

Pre-exposure prophylaxis, or PrEP, and “test-and-treat” methods are both more cost-effective than the current strategy for the prevention of HIV transmission among men who have sex with men, according to researchers. The success of either strategy, however, depends on treatment initiation and adherence. “ infects approximately ...

Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use PrEP, Asa Radix of the Callen-Lorde Community Health Center in New York told the recent 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. The need ...

Discovery of a novel, advanced technique to identify the rare cells where HIV hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure. Why wake up the virus? To better kill it, of course. A team ...

Remarks given by Michel Kazatchkine, UN Secretary-General Special Envoy on HIV/AIDS in Eastern Europe and Central Asia, at Sixty-sixth session of the WHO Regional Committee for Europe in Copenhagen, September 14, 2016 Madame Chair, Madame Director General, I would like to thank the Regional Office for framing ...

The development of drug resistance in Mycobacterium tuberculosis was first documented in the late 1940s, soon after antibiotic therapy was introduced for tuberculosis treatment. It quickly became obvious that combination chemotherapy could prevent the emergence of drug resistance and that patients infected with drug-resistant strains ...

At its September meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Truvada – Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine/tenofovir disoproxil) for the treatment of HIV infection. Summary of opinion for Emtricitabine/Tenofovir disoproxil Zentiva is available here. Original ...